Anita Z. Graham
CIK: 0001206814
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LABCORP HOLDINGS INC.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Mar 26, 2026LH
LABCORP HOLDINGS INC.
Award(A)Direct6.6K shares- - Mar 26, 2026LH
LABCORP HOLDINGS INC.
Tax Payment(F)Direct2.9K shares at avg. $268.38$773K - Feb 11, 2026LH
LABCORP HOLDINGS INC.
Tax Payment(F)Direct109 shares at avg. $289.89$32K - Feb 11, 2026LH
LABCORP HOLDINGS INC.
Exercise(M)Direct356 shares- - Feb 10, 2026LH
LABCORP HOLDINGS INC.
Award(A)DirectRestricted Stock Unit
1.4K shares- - Feb 10, 2026LH
LABCORP HOLDINGS INC.
Award(A)DirectNon-qualified Stock Options
4.1K shares- - Feb 9, 2026LH
LABCORP HOLDINGS INC.
Tax Payment(F)Direct112 shares at avg. $274.01$31K - Feb 7, 2026LH
LABCORP HOLDINGS INC.
Exercise(M)Direct367 shares- - Feb 6, 2026LH
LABCORP HOLDINGS INC.
Tax Payment(F)Direct119 shares at avg. $277.20$33K - Feb 6, 2026LH
LABCORP HOLDINGS INC.
Exercise(M)Direct327 shares- - Feb 11, 2025LH
LABCORP HOLDINGS INC.
Award(A)DirectNon-qualified Stock Options
3.2K shares- - Feb 11, 2025LH
LABCORP HOLDINGS INC.
Award(A)DirectRestricted Stock Unit
1.1K shares- - Feb 7, 2025LH
LABCORP HOLDINGS INC.
Exercise(M)Direct369 shares- - Feb 7, 2025LH
LABCORP HOLDINGS INC.
Tax Payment(F)Direct119 shares at avg. $246.27$29K - Feb 6, 2025LH
LABCORP HOLDINGS INC.
Exercise(M)Direct326 shares- - Feb 6, 2025LH
LABCORP HOLDINGS INC.
Tax Payment(F)Direct118 shares at avg. $247.74$29K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 26, 2026 | LH LABCORP HOLDINGS INC. | Award(A) | 6,604 | - | $0 | Direct |
| Mar 26, 2026 | LH LABCORP HOLDINGS INC. | Tax Payment(F) | 2,879 | $268.38 | $772,666 | Direct |
| Feb 11, 2026 | LH LABCORP HOLDINGS INC. | Tax Payment(F) | 109 | $289.89 | $31,598 | Direct |
| Feb 11, 2026 | LH LABCORP HOLDINGS INC. | Exercise(M) | 356 | - | $0 | Direct |
| Feb 10, 2026 | LH LABCORP HOLDINGS INC. | Award(A) Restricted Stock Unit | 1,360 | - | - | Direct |
| Feb 10, 2026 | LH LABCORP HOLDINGS INC. | Award(A) Non-qualified Stock Options | 4,100 | - | - | Direct |
| Feb 9, 2026 | LH LABCORP HOLDINGS INC. | Tax Payment(F) | 112 | $274.01 | $30,689 | Direct |
| Feb 7, 2026 | LH LABCORP HOLDINGS INC. | Exercise(M) | 367 | - | $0 | Direct |
| Feb 6, 2026 | LH LABCORP HOLDINGS INC. | Tax Payment(F) | 119 | $277.20 | $32,987 | Direct |
| Feb 6, 2026 | LH LABCORP HOLDINGS INC. | Exercise(M) | 327 | - | $0 | Direct |
| Feb 11, 2025 | LH LABCORP HOLDINGS INC. | Award(A) Non-qualified Stock Options | 3,200 | - | - | Direct |
| Feb 11, 2025 | LH LABCORP HOLDINGS INC. | Award(A) Restricted Stock Unit | 1,070 | - | - | Direct |
| Feb 7, 2025 | LH LABCORP HOLDINGS INC. | Exercise(M) | 369 | - | - | Direct |
| Feb 7, 2025 | LH LABCORP HOLDINGS INC. | Tax Payment(F) | 119 | $246.27 | $29,306 | Direct |
| Feb 6, 2025 | LH LABCORP HOLDINGS INC. | Exercise(M) | 326 | - | - | Direct |
| Feb 6, 2025 | LH LABCORP HOLDINGS INC. | Tax Payment(F) | 118 | $247.74 | $29,233 | Direct |
1-16 of 16 transactions
About GRAHAM ANITA Z
GRAHAM ANITA Z (SEC CIK 0001206814) files insider reports with the SEC as EVP, CHRO of LABCORP HOLDINGS INC. (LH).
Signal8 holds 6 ownership filings by GRAHAM ANITA Z, all Form 4s, filed between Feb 10, 2025 and Mar 30, 2026. Those filings report 16 transactions, from Feb 6, 2025 to Mar 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GRAHAM ANITA Z's filings is in BURLINGTON, NC.
Recent filings by GRAHAM ANITA Z
- Mar 26, 2026: Grant or award of LH shares (Form 4, code A).
- Mar 26, 2026: Tax withholding of LH shares (Form 4, code F).
- Feb 11, 2026: Tax withholding of LH shares (Form 4, code F).
- Feb 11, 2026: Option exercise of LH shares (Form 4, code M).
- Feb 10, 2026: Grants or awards of LH derivative securities (2 lines, Form 4, code A).
Other insiders filing for LABCORP HOLDINGS INC. (LH)
- Parham Richelle P, Director
- Oyegunwa Akinbolade, EVP, CIO & CTO
- Vaughn Bryan T, EVP and President, Diagnostics
- Meltzer Jonathan C, EVP, COO
- Caveney Brian J, EVP, Pres of BLS, CMO & CSO
- ANDERSON KERRII B, Director